Beximco Pharma (BXP.L): Appointment of Independent Non-Executive Director | Polarean Imaging (POLX.L): Scientific presentations on hyperpolarized Xenon 129 at academic conferences | Diurnal (DNL.L): Trading Update and meeting with US FDA regarding DITEST™ product

30 Jul 2020
SP Angel Healthcare Conditions- 30-07-2020

Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
SP Angel Healthcare Conditions- 30-07-2020
Beximco Pharmaceuticals Limited Sponsored GDR RegS (BXP:LON), 36.0 | Polarean Imaging Plc (POLX:LON), 0.9
- Published:
30 Jul 2020 -
Author:
Vadim Alexandre | Liam Gascoigne-Cohen -
Pages:
3 -
Beximco Pharma (BXP.L): Appointment of Independent Non-Executive Director | Polarean Imaging (POLX.L): Scientific presentations on hyperpolarized Xenon 129 at academic conferences | Diurnal (DNL.L): Trading Update and meeting with US FDA regarding DITEST™ product